GC

Greenlight Capital Portfolio holdings

AUM $2.05B Turnover 28.26%
1-Year Est. Return 78.75%
This Fund
S&P 500
This Quarter Est. Return
-12.44%
1 Year Est. Return
+78.75%
3 Year Est. Return
+169.15%
5 Year Est. Return
+457.09%
10 Year Est. Return
+683.15%
AUM
$1.29B
AUM Growth
-$288M
Cap. Flow
-$76.4M
Cap. Flow %
-5.94%
Top 10 Hldgs %
73.63%
Holding
55
New
3
Increased
11
Reduced
7
Closed
8
Avg Time Held
1.4 years
Top 10 Avg Time Held
1.7 years
Top 20 Avg Time Held
1.6 years

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 36.41%
2 Industrials 13.17%
3 Energy 11.69%
4 Financials 11.37%
5 Technology 8.56%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
NWS icon
26
News Corp Class B
NWS
$17.5B
$5.74M 0.45%
361,291
– –
2021 Q2
4 quarters
PLBY icon
27
Playboy Inc
PLBY
$119M
$5.25M 0.41%
820,000
– –
2021 Q2
4 quarters
DNMR icon
28
DELISTED
Danimer Scientific, Inc.
DNMR
$3.74M 0.29%
20,525
– –
2020 Q4
6 quarters
CNX icon
29
CNX Resources
CNX
$5.15B
$3.67M 0.29%
222,715
– –
2014 Q3
31 quarters
WAVC.U
30
DELISTED
Waverley Capital Acquisition Corp. 1 Units, each consisting of one Class A Ordinary Share and one-third of one redeemable warrant
WAVC.U
$3.4M 0.26%
350,000
– –
2021 Q3
3 quarters
FSRXU
31
DELISTED
FinServ Acquisition Corp. II Unit
FSRXU
$3.09M 0.24%
315,000
– –
2021 Q1
5 quarters
NBSE icon
32
DELISTED
NeuBase Therapeutics, Inc. Common Stock
NBSE
$2.86M 0.22%
136,351
– –
2019 Q3
11 quarters
ASTS icon
33
AST SpaceMobile
ASTS
$12.6B
$2.69M 0.21%
427,500
– –
2020 Q4
6 quarters
PANA
34
DELISTED
Panacea Acquisition Corp. II Class A Ordinary Shares
PANA
$2.68M 0.21%
275,000
– –
2021 Q2
4 quarters
GANX icon
35
Gain Therapeutics
GANX
$57.6M
$1.97M 0.15%
546,560
– –
2021 Q1
5 quarters
RIVN icon
36
Rivian
RIVN
$18.7B
$1.9M 0.15%
+73,723
New +$2.3M
2022 Q2
0 quarters
TLIS icon
37
DELISTED
Talis Biomedical Corporation Common Stock
TLIS
$1.82M 0.14%
149,052
– –
2021 Q4
2 quarters
XLE icon
38
State Street Energy Select Sector SPDR ETF
XLE
$43.5B
$1.05M 0.08%
29,400
– –
2022 Q1
1 quarter
PSNYW icon
39
Polestar Automotive Holding ADS Class C-1
PSNYW
$651M
$137K 0.01%
+2,737
New +$189K
2022 Q2
0 quarters
NUVB icon
40
Nuvation Bio
NUVB
$1.64B
$113K 0.01%
34,995
– –
2020 Q3
7 quarters
PSFE.WS icon
41
DELISTED
Paysafe Ltd Warrants
PSFE.WS
$78K 0.01%
288,000
– –
2021 Q1
5 quarters
ME icon
42
DELISTED
23andMe Holding Co
ME
$59K ﹤0.01%
1,180
-2,500
-68% -$145K
2021 Q4
2 quarters
KPLTW icon
43
DELISTED
Katapult Holdings Warrant
KPLTW
$39K ﹤0.01%
262,227
– –
2021 Q1
5 quarters
TMCWW
44
DELISTED
TMC The Metals Company Warrants
TMCWW
$34K ﹤0.01%
170,000
– –
2021 Q3
3 quarters
NUVB.WS icon
45
DELISTED
Nuvation Bio Inc Warrants
NUVB.WS
$28K ﹤0.01%
100,000
– –
2021 Q1
5 quarters
BKSY.WS icon
46
DELISTED
BlackSky Technology Inc Warrants
BKSY.WS
$15K ﹤0.01%
36,200
– –
2021 Q3
3 quarters
BODY.WS
47
DELISTED
The Beachbody Company, Inc. Redeemable Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50
BODY.WS
$10K ﹤0.01%
57,000
– –
2021 Q2
4 quarters
EVGOW icon
48
DELISTED
EVgo Inc Warrants
EVGOW
– –
-31,000
Closed -$121K –
FCG icon
49
First Trust Natural Gas ETF
FCG
$662M
– –
-34,000
Closed -$829K –
GPOR icon
50
Gulfport Energy Corp
GPOR
$2.93B
– –
-113,136
Closed -$10.2M –

Similar funds

Greenlight Capital's Q2 2022 Portfolio in Review

As of Q2 2022, Greenlight Capital held 55 positions worth $1.29B, down 18% from $1.57B the previous quarter. Its ten largest holdings account for 74% of the portfolio.

Greenlight Capital withdrew a net $76.4M in Q2 2022, closing 8 positions and reducing 7 holdings. Its most notable exit was TD Synnex, an estimated $17.3M position sold in full.

By sector, the portfolio is most concentrated in Consumer Discretionary at 36% of assets, up from 31% a quarter earlier, followed by Industrials and Energy.

Against the trend, Greenlight Capital opened a new position in Concentrix worth $6.07M.

  • Greenlight Capital's largest Q2 2022 buy was Concentrix: 44,733 shares worth $6.07M.
  • Greenlight Capital added most to Kyndryl in Q2 2022, an estimated $34.4M increase.
  • Greenlight Capital's biggest Q2 2022 reduction was Change Healthcare Inc. Common Stock, cutting an estimated $53.2M.
  • Greenlight Capital fully exited TD Synnex in Q2 2022, selling an estimated $17.3M.
  • Greenlight Capital's ten largest holdings make up 74% of its $1.29B portfolio in Q2 2022.
  • Greenlight Capital opened 3 new positions and closed 8 in Q2 2022.
  • Greenlight Capital's portfolio value fell 18% quarter-over-quarter to $1.29B.

Based on Greenlight Capital's 13F filing for Q2 2022, filed 15 Aug 2022.